These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8892346)
1. Glycation and microglial reaction in lesions of Alzheimer's disease. Dickson DW; Sinicropi S; Yen SH; Ko LW; Mattiace LA; Bucala R; Vlassara H Neurobiol Aging; 1996; 17(5):733-43. PubMed ID: 8892346 [TBL] [Abstract][Full Text] [Related]
2. Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer beta-amyloid deposition. Yamaguchi H; Ishiguro K; Sugihara S; Nakazato Y; Kawarabayashi T; Sun X; Hirai S Acta Neuropathol; 1994; 88(5):413-9. PubMed ID: 7847069 [TBL] [Abstract][Full Text] [Related]
3. Regional differences in apolipoprotein E immunoreactivity in diffuse plaques in Alzheimer's disease brain. Kida E; Golabek AA; Wisniewski T; Wisniewski KE Neurosci Lett; 1994 Feb; 167(1-2):73-6. PubMed ID: 8177532 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's disease. Namba Y; Tsuchiya H; Ikeda K Neurosci Lett; 1992 Jan; 134(2):264-6. PubMed ID: 1375354 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Namba Y; Tomonaga M; Kawasaki H; Otomo E; Ikeda K Brain Res; 1991 Feb; 541(1):163-6. PubMed ID: 2029618 [TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946 [TBL] [Abstract][Full Text] [Related]
7. C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease. Duong T; Nikolaeva M; Acton PJ Brain Res; 1997 Feb; 749(1):152-6. PubMed ID: 9070642 [TBL] [Abstract][Full Text] [Related]
8. The cellular pathology associated with Alzheimer beta-amyloid deposits in non-demented aged individuals. Coria F; Moreno A; Rubio I; García MA; Morato E; Mayor F Neuropathol Appl Neurobiol; 1993 Jun; 19(3):261-8. PubMed ID: 8355812 [TBL] [Abstract][Full Text] [Related]
9. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Sparks DL Ann N Y Acad Sci; 1997 Sep; 826():128-46. PubMed ID: 9329686 [TBL] [Abstract][Full Text] [Related]
10. Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. Perry G; Cras P; Siedlak SL; Tabaton M; Kawai M Am J Pathol; 1992 Feb; 140(2):283-90. PubMed ID: 1739122 [TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease. Perry G; Richey PL; Siedlak SL; Smith MA; Mulvihill P; DeWitt DA; Barnett J; Greenberg BD; Kalaria RN Am J Pathol; 1993 Dec; 143(6):1586-93. PubMed ID: 7504885 [TBL] [Abstract][Full Text] [Related]
12. [Expression of apolipoprotein E in Alzheimer's disease and its significance]. He SR; Liu DG; Wang S; Xia YJ Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517 [TBL] [Abstract][Full Text] [Related]
14. [Apolipoprotein B immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in senile dementia of Alzheimer type]. Namba Y; Ikeda K Rinsho Shinkeigaku; 1991 Aug; 31(8):826-30. PubMed ID: 1764857 [TBL] [Abstract][Full Text] [Related]
15. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Schwab C; Hosokawa M; McGeer PL Exp Neurol; 2004 Jul; 188(1):52-64. PubMed ID: 15191802 [TBL] [Abstract][Full Text] [Related]
17. Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease. Münch G; Cunningham AM; Riederer P; Braak E Brain Res; 1998 Jun; 796(1-2):307-10. PubMed ID: 9689484 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non-demented and Alzheimer's disease patients. Gómez-Ramos P; Mufson EJ; Morán MA Microsc Res Tech; 2001 Oct; 55(1):48-58. PubMed ID: 11596149 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006 [TBL] [Abstract][Full Text] [Related]